GC
PFE icon

Gould Capital’s Pfizer PFE Stock Holding History

Gould Capital’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$28.1K Hold
1,000
– – 0.02% 111
2025
Q4 		$24.9K Hold
1,000
– – 0.02% 110
2025
Q3 		$25.5K Hold
1,000
– – 0.02% 111
2025
Q2 		$24.2K Hold
1,000
– – 0.02% 107
2025
Q1 		$25.3K Hold
1,000
– – 0.02% 102
2024
Q4 		$26.5K Buy
1,000
+493
+97% +$13.4K 0.02% 109
2024
Q3 		$14.7K Buy
507
+7
+1% +$204 0.01% 137
2024
Q2 		$14K Hold
500
– – 0.01% 137
2024
Q1 		$13.9K Buy
+500
New +$13.9K 0.01% 134
2022
Q4 		– Sell
-40
Closed -$2K – 213
2022
Q3 		$2K Hold
40
– – ﹤0.01% 178
2022
Q2 		$2K Hold
40
– – ﹤0.01% 189
2022
Q1 		$2K Sell
40
-487
-92% -$25.3K ﹤0.01% 181
2021
Q4 		$31K Buy
+527
New +$26.1K 0.02% 105

Other funds holding PFE

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

Gould Capital's PFE Position: Q1 2026 in Review

Gould Capital held its Pfizer (PFE) position steady in Q1 2026 at 1,000 shares worth $28.1K. The position accounts for 0.02% of the portfolio, ranked #111.

Gould Capital first reported a position in PFE in Q4 2021 and has held it in 13 quarters since. The position peaked at $31K in Q4 2021. 2,937 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

  • Gould Capital held 1,000 shares of Pfizer worth $28.1K as of Q1 2026.
  • Gould Capital left its Pfizer share count unchanged in Q1 2026.
  • Pfizer made up 0.02% of Gould Capital's portfolio in Q1 2026, its #111 holding.
  • Gould Capital first reported a position in Pfizer in Q4 2021 and has held it in 13 quarters since.
  • Gould Capital's Pfizer position peaked at $31K in Q4 2021.
  • 2,937 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on Gould Capital's 13F filing for Q1 2026, filed 18 May 2026.